BetaGlue Technologies, founded in 2009, is a pioneer in precision radiotherapy with its advanced platform YntraDose. The Italy-based biotechnology startup focuses on providing localised targeted treatment for unresectable solid tumors and surgical resection margins. The company's recent €8.00M Venture Round investment on June 6, 2024 garnered support from prominent investors including LIFTT, Neva SGR, Fin Posillipo Spa, Romed, and Giovanni Cerutti.
BetaGlue Therapeutics
Precision Radiotherapy From Within
Founded 2009
Italy
17 employees
Series Unknown
Total: $28.00M
Biotechnology, Health Care +1
Italy
17 employees
Series Unknown
Total: $28.00M
Biotechnology, Health Care +1
General Information
Get notified when BetaGlue Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track BetaGlue Therapeutics
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Italy Market
Biotechnology
About BetaGlue Therapeutics
Taxonomy: oncology, radiotherapy, clinical stage, treatment, solid tumors, surgical resection, targeted treatment, internal β-emitting, localized therapy, advanced platform
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | •••••• | 5 |
|
06 Jun 2024 |
| Grant | •••••• | 1 | •••• •••• | 04 Mar 2024 |
| Seed Round | •••••• | 1 | •••• •••• | 28 Feb 2024 |
| Seed Round | •••••• | 3 |
|
20 Jul 2022 |
BetaGlue Therapeutics Alternatives & Competitors
BetaGlue Therapeutics vs
Aquatic Solutions
India
Water & Wastewater Company. Water Recycle & Reuse. Manufacturers & Suppliers
44 employees
Manufacturing, Waste Solution
BetaGlue Therapeutics vs
#AdventureHeals - Excellence - Humility - Courage
57 employees
Health Care, Health and Wellness
BetaGlue Therapeutics vs
FAQ About BetaGlue Therapeutics
Precision Radiotherapy From Within
BetaGlue Therapeutics was founded in 2009.
BetaGlue Therapeutics is headquartered in Italy.
BetaGlue Therapeutics operates in the following industries: Biotechnology, Health Care, Health and Wellness.
BetaGlue Therapeutics has approximately 17 employees.
BetaGlue Therapeutics has completed 4 funding rounds, raising a total of $28.00M. The latest funding stage is Series Unknown.
Top alternatives and competitors to BetaGlue Therapeutics include Aquatic Solutions, Aspiro Adventure Therapy, Franklin Water Treatment, Brighton Recovery Center, The Delray Center. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BetaGlue Therapeutics and Aquatic Solutions are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors BetaGlue Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
